ESTRO 2024 - Abstract Book

S2780

Interdisciplinary - Health economics & health services research

ESTRO 2024

Even in a public sector hospital like ours, cancer patients face considerable OOPE during treatment. The number of patients covered by any kind of insurance is low. The scope of increasing the population under the national health insurance scheme is needed. Access to quality cancer care nearer home could decrease the direct and indirect OOPE.

Keywords: OOPE, financial protection, health insurance

References:

1. Chang S et al. Estimating the cost of cancer:results on the basis of claimsdata analyses for cancer patients diagnosed with seven types of cancerduring 1999 to 2000.Journal of Clinical Oncology.2004 Sep 1; 22(17): 3524 - 30

2. Rajpal S et al. Economic burden of cancer in India: Evidence from cross-sectional national representative household survey. PloS One 2018 Feb 26;13(2): e0193320

3. Ghoshal S, Arora M et al.The socio-economic burden of cancer: An observation from the palliative care OPD. Journal of Family Medicine and Primary care.2022; Mar 11(3): 821

675

Mini-Oral

Young radiation oncology professionals’ perspective on job satisfaction, recruitment and retention

Dylan Callens 1,2 , Amanda Webster 1,3 , Azadeh Abravan 1,4 , Jenny Bertholet 1,5 , Andrea Collavini 1 , Morten Horsholt Kristensen 1,6 , Pierre Montay-Gruel 1,7 , Daan Nevens 1,7 , Sophie Perryck 1,8 , Steven Petit 1,9 , Daniel Portik 1,10 , Bartłomiej Tomasik 1,11 , Jolien Heukelom 1,12 1 ESTRO, YoungESTRO Committee, Brussels, Belgium. 2 University Hospital Leuven, Department of Radiation Oncology, Leuven, Belgium. 3 University College London Hospital NHS Foundation Trust, UCLH Radiotherapy and PBT Department, London, United Kingdom. 4 University of Manchester, Department of Radiotherapy Related Research, Manchester, United Kingdom. 5 University Hospital and University of Bern, Division of Medical Radiation Physics and Department of Radiation Oncology, Bern, Switzerland. 6 Aarhus University Hospital, : Dept. of Experimental Clinical Oncology, Aarhus, Denmark. 7 Iridium Netwerk, Radiotherapy Department Center for Oncological Research (CORE), Antwerp Research in Radiation Oncology (AReRO), Integrated Personalized and Precision Oncology Network (IPPON), Antwerp, Belgium. 8 University Hospital Zürich, Department of Radiation Oncology, Zürich, Switzerland. 9 Erasmus MC Cancer Institute, Department of Radiotherapy, Rotterdam, Netherlands. 10 European Organisation for Research and Treatment of Cancer (EORTC), EORTC, Brussels, Belgium. 11 Medical University of Gdańsk, Department of Oncology and Radiotherapy, Gdansk, Poland. 12 Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro), Maastricht, Netherlands

Purpose/Objective: